Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1058823.RA-75cGNO2XL9rnDcxRgADGcLw9SvFg4vDzeDA7_s9cz8130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1058823.RA-75cGNO2XL9rnDcxRgADGcLw9SvFg4vDzeDA7_s9cz8130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1058823.RA-75cGNO2XL9rnDcxRgADGcLw9SvFg4vDzeDA7_s9cz8130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1058823.RA-75cGNO2XL9rnDcxRgADGcLw9SvFg4vDzeDA7_s9cz8130_provenance.
- befree-2016 importedOn "2016-02-19" NP1058823.RA-75cGNO2XL9rnDcxRgADGcLw9SvFg4vDzeDA7_s9cz8130_provenance.
- NP1058823.RA-75cGNO2XL9rnDcxRgADGcLw9SvFg4vDzeDA7_s9cz8130_assertion wasGeneratedBy ECO_0000203 NP1058823.RA-75cGNO2XL9rnDcxRgADGcLw9SvFg4vDzeDA7_s9cz8130_provenance.
- NP1058823.RA-75cGNO2XL9rnDcxRgADGcLw9SvFg4vDzeDA7_s9cz8130_assertion wasDerivedFrom befree-2016 NP1058823.RA-75cGNO2XL9rnDcxRgADGcLw9SvFg4vDzeDA7_s9cz8130_provenance.
- NP1058823.RA-75cGNO2XL9rnDcxRgADGcLw9SvFg4vDzeDA7_s9cz8130_assertion SIO_000772 23470485 NP1058823.RA-75cGNO2XL9rnDcxRgADGcLw9SvFg4vDzeDA7_s9cz8130_provenance.
- NP1058823.RA-75cGNO2XL9rnDcxRgADGcLw9SvFg4vDzeDA7_s9cz8130_assertion evidence source_evidence_literature NP1058823.RA-75cGNO2XL9rnDcxRgADGcLw9SvFg4vDzeDA7_s9cz8130_provenance.
- NP1058823.RA-75cGNO2XL9rnDcxRgADGcLw9SvFg4vDzeDA7_s9cz8130_assertion description "[The selectivity of TRAIL towards cancer cells has promoted clinical evaluation of recombinant human TRAIL (rhTRAIL) and its agonistic antibodies in treating several major human cancers including colon and non-Hodgkin's lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1058823.RA-75cGNO2XL9rnDcxRgADGcLw9SvFg4vDzeDA7_s9cz8130_provenance.